Offer - Urjas Oil for just ₹ 1
Doxotero 50 Injection, a prescription drug, is manufactured in various forms such as Injection. It is primarily used for the treatment of Blood Cancer. Secondary and off-label uses of Doxotero 50 Injection have also been mentioned below.
The correct dosage of Doxotero 50 Injection depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Doxotero 50 Injection also has some side effects, the most common being Hair Loss. Besides the aforementioned side effects, there are other adverse effects of Doxotero 50 Injection as well, which are listed below. These side effects of Doxotero 50 Injection are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Doxotero 50 Injection's effect during pregnancy is Severe and Severe while nursing. It is important to know if Doxotero 50 Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Doxotero 50 Injection related warnings section.
Doxotero 50 Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Failure are examples of such conditions. The section on Doxotero 50 Injection contraindications lists all such conditions.
Additionally, Doxotero 50 Injection may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Doxotero 50 Injection, it is important to know that it is not safe while driving, and is not habit-forming.
Doxotero 50 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Adult(Female) |
|
Geriatric |
|
Is the use of Doxotero 50 Injection safe for pregnant women?
Doxotero can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Doxotero 50 Injection safe during breastfeeding?
Doxotero should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Doxotero 50 Injection on the Kidneys?
Doxotero is not harmful for kidneys.
What is the effect of Doxotero 50 Injection on the Liver?
You may experience side effects on your liver after taking Doxotero. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Doxotero 50 Injection on the Heart?
The heart can be affected by Doxotero. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Doxotero 50 Injection unless your doctor advises you to do so -
Is this Doxotero 50 Injection habit forming or addictive?
No, there is no any evidence that Doxotero 50 Injection is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Doxotero 50 Injection. So it is best to avoid driving.
Is it safe?
Doxotero 50 Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Doxotero 50 Injection for mental disorders.
Interaction between Food and Doxotero 50 Injection
Taking Doxotero 50 Injection with food does not harm your health.
Interaction between Alcohol and Doxotero 50 Injection
No research has been done on this till date. Therefore, it is not known what the effect of taking Doxotero 50 Injection with alcohol will be.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 463-465
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 867
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Adriamycin (doxorubicin hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Doxorubicin Hydrochloride (doxorubicin hydrochloride)